Dimethylarginine dimethylaminohydrolase (DDAH) proteins have significantly advanced our understanding of cardiovascular disease mechanisms (21, 22, 23, 24, 25) and are valued as diagnostic markers (26) and therapeutic targets (27). Here, DDAH2 is linked to cardiovascular disorder.